Synthesis and antibacterial evaluations of new pyridazino[4,3‐e][1,3,4]oxadiazines

Several derivatives of the new pyridazino[4,3‐e][1,3,4]oxadiazine ring system were prepared, and their antibacterial evaluations were performed on four different Gram‐negative and Gram‐positive bacteria. J. Heterocyclic Chem., (2010).     

A novel method for the reduction of sulfoxides with the N,N,N’,N’-tetrabromobenzene-1,3-disulfonamide (TBBDA)/PPh3 system

A new method is described for the reduction of sulfoxides to sulfides using N,N,N’,N’-tetrabromobenzene-1,3-disulfonamide [TBBDA] in combination with triphenylphosphine. Good to excellent yields, short reaction times, high efficiency and facile isolation of the desired products are the advantages of this method.     

A new and facile access to the 2-(indol-3-yl)-3-nitriloquinolines based on Friedländer annulations

Preparation of 2-(indol-3-yl)-3-nitriloquinolines via Friedländer quinoline synthesis using 3-cyanoacetylindoles possessing an α-methylene group and ortho-amino arylketones have been described. This reaction took place in PEG-400 as a green solvent and it is catalyzed with polyphosphoric acid (PPA) to give novel types of quinolines containing both indoles and cyano functions in one step under thermal and microwave conditions.     

AN EFFICIENT PRO CEDURE FOR THE PREPARATION OF MONO,AND DI-BIS-INDOLYL METHANES CATALYZED BY MOLIBDATOPHOSPHORIC ACID

H ₃ PMo ₁₂ O ₄₀ · xH ₂ O was found to be an effective catalyst for the preparation of bis-indolyl derivatives from indole and aromatic, aliphatic, heterocyclic aldehydes or ketones in ethanol at room temperature.     

Recent Strategies in Transition-Metal-Catalyzed Sequential C–H Activation/Annulation for One-Step Construction of Functionalized Indazole Derivatives

Designing new synthetic strategies for indazoles is a prominent topic in contemporary research. The transition-metal-catalyzed C–H activation/annulation sequence has arisen as a favorable tool to construct functionalized indazole derivatives with improved tolerance in medicinal applications, functional flexibility, and structural complexity. In the current review article, we aim to outline and summarize the most common synthetic protocols to use in the synthesis of target indazoles via a transition-metal-catalyzed C–H activation/annulation sequence for the one-step synthesis of functionalized indazole derivatives. We categorized the text according to the metal salts used in the reactions. Some metal salts were used as catalysts, and others may have been used as oxidants and/or for the activation of precatalysts. The roles of some metal salts in the corresponding reaction mechanisms have not been identified. It can be expected that the current synopsis will provide accessible practical guidance to colleagues interested in the subject.     

Synthesis,Characterization, and Docking Evaluations of New Derivatives of Pyrimido[4,5‐c]pyridazine as Potential Human AKT1 Inhibitors

A number of new derivatives of pyrimido[4,5‐c]pyridazine have been synthesized from the treatment of 6‐acetyl‐3‐amino‐2,5‐diphenyl‐2,5‐dihydropyridazine‐4‐carbonitrile ( 1 ) as precursor with various reactants obtained quantitatively the desired products ( 2 ), ( 5 ), ( 7 ), and ( 9a , 9b , 9c , 9d , 9e ). The structures of all the synthesized products have been elucidated thoroughly. The potential AKT1 inhibitory activities of these new synthesized compounds have also been studied by docking calculations, which have been performed in Gold 5.2 software using Genetic algorithm.     

Synthesis of Oxazolo[5,4‐d][1,2,4]triazolo[4,3‐a]pyrimidines as a New Class of Heterocyclic Compounds

Several new derivatives of oxazolo[5,4‐d]pyrimidine ( 3a , 3b , 3c , 3d , 3e , 3f , 3g , 3h ) have been synthesized through the reaction of 2,4‐dichloro‐6‐methyl‐5‐nitropyrimidine ( 2 ) with aryl carboxylic acids in refluxing POCl₃. Further treatment of compounds ( 3a , 3b , 3c , 3d , 3e , 3f , 3g , 3h ) with hydrazine hydrate gave the hydrazine derivatives ( 4a , 4b , 4c , 4d , 4e , 4f , 4g , 4h ) that were subsequently cyclized into a novel heterocyclic system, oxazolo[5,4‐d][1,2,4]triazolo[4,3‐a]pyrimidine ( 5a , 5b , 5c , 5d , 5e , 5f , 5g , 5h , 5i , 5j , 5k , 5l , 5m , 5n , 5o , 5p ) and ( 7a , 7b , 7c , 7d ) on treatment with triethylorthoesters or carbondisulfide and alkylhalides, respectively.